-
Pharmaceutical companies, WHO help India in HIV/AIDS drug crisis
(Reuters) - Indian companies and global health groups are stepping up efforts to provide a critical medicine for the country's free HIV/AIDS drugs program after more than 150,000 patients risked going without their dosages this month.
- Categories
- Health Care
- Region
- South Asia
-
Here’s How Nigeria Beat Ebola
It took 18,500 interviews, but Nigeria managed to contain the Ebola outbreak.
- Categories
- Education, Health Care
- Region
- Sub-Saharan Africa
-
Pfenex And PATH Partner On Vaccines
Pfenex Inc., a clinical-stage biotechnology company engaged in the development of high-value biosimilar therapeutics and difficult to manufacture proteins, today announced the initiation of a multi-product research program with PATH.
- Categories
- Health Care
-
Ebola cost to W.Africa economy could top $32 bn: World Bank
The deadly Ebola epidemic could deal a $32 billion-plus blow to the West African economy over the next year if officials cannot get it under control, the World Bank warned Wednesday.
- Categories
- Health Care
- Region
- Sub-Saharan Africa
-
Ebola outbreak: Where are the mHealth apps?
The Ebola outbreak in West Africa and now the U.S. is surely among the most high-profile incidents wherein mobile health technologies could have proven their mettle.
- Categories
- Health Care, Technology
- Region
- Sub-Saharan Africa
-
Firestone Did What Governments Have Not: Stopped Ebola In Its Tracks
Firestone detected its first Ebola case on March 30, when an employee's wife arrived from northern Liberia. Since then Firestone has done a remarkable job of keeping the virus at bay.
- Categories
- Health Care
- Region
- Sub-Saharan Africa
-
Vaccines targeting adults, teens best chance to eliminate TB
Targets to eliminate tuberculosis (TB) by 2050 are more likely to be met if new vaccines are developed for adults and adolescents rather than infants, according to a new research.
- Categories
- Health Care
-
Ebola Vaccine Trials May Give Placebo to Those at Risk
As global health officials rush to begin human trials of two promising Ebola vaccines in West African medical workers, a daunting question remains unanswered: Who gets the placebo injection?
- Categories
- Health Care
- Region
- Sub-Saharan Africa
Subscribe to Our Weekly Newsletter, "NextBillion Notes"
Published each Wednesday, our e-newsletter features NextBillion's latest original articles, along with a selection of news, jobs, bizdev opportunities and events from our recent coverage — and regular conference ticket giveaways.
We respect your privacy. Your information is safe and will never be shared.
Don't miss out. Subscribe today.